ARZNEIMITTEL ZUR BEHANDLUNG VON DIABETES MELLITUS

A pharmaceutical preparation for the treatment of diabetes mellitus comprising the following components, in percent by weight: crystalline insulin with a conventional 1 to 25.0 activity of 1 mg = 20 units additives inhibiting deactivation of insulin, 0.02 to 10.0 viz. 5-(para-[N-(3-methoxypyridaziny...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DAVYDOV, ANATOLY BORISOVICH, METELITSA, VLADIMIR ISAAKOVICH, CHAZOV, EVGENY IVANOVICH, KHROMOV, GENNADY LVOVICH, OSTROVSKAYA, TAMARA PETROVNA, BABAIAN, EDUARD ARMENAKOVICH, UTYAMYSHEV, RUSTAM ISMAILOVICH
Format:	Patent
Sprache:	ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A pharmaceutical preparation for the treatment of diabetes mellitus comprising the following components, in percent by weight: crystalline insulin with a conventional 1 to 25.0 activity of 1 mg = 20 units additives inhibiting deactivation of insulin, 0.02 to 10.0 viz. 5-(para-[N-(3-methoxypyridazinyl-6)- sulphamido]-phenylazo)-salicylic acid, calcium gluconate or a mixture thereof preservatives 0.1 to 15.0 additives adjusting solubility of 0.01 to 10.0 insulin water-soluble polymeric base the balance.